BIOMAT Database Logo BIOMAT Database Logo

Treatment of Hepatitis C Virus Genotype 3 Infection. 2015

Fred Poordad
Clinical Professor of Medicine Chief, Hepatology University of Texas Health Science Center VP, Academic and Clinical Affairs Texas Liver Institute San Antonio, Texas.

UI MeSH Term Description Entries

Related Publications

Fred Poordad
Treatment of hepatitis C virus genotype 3-infection.
February 2014, Liver international : official journal of the International Association for the Study of the Liver,
Fred Poordad
Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents.
October 2016, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Fred Poordad
Genotype 3 Infection: The Last Stand of Hepatitis C Virus.
February 2017, Drugs,
Fred Poordad
Treatment of genotype 2 and genotype 3 hepatitis C virus (HCV) infection in human immunodeficiency virus positive patients.
December 2013, Current HIV/AIDS reports,
Fred Poordad
Hepatitis C Genotype 3 Infection: Pathogenesis and Treatment Horizons.
November 2017, Clinics in liver disease,
Fred Poordad
Dual daclatasvir and sofosbuvir for treatment of genotype 3 chronic hepatitis C virus infection.
January 2016, Expert review of gastroenterology & hepatology,
Fred Poordad
Super-infection with genotype 4 hepatitis C virus in a patient treated for genotype 3 acute hepatitis C.
March 2012, AIDS (London, England),
Fred Poordad
IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.
March 2011, Hepatology (Baltimore, Md.),
Fred Poordad
Protease inhibitors for treatment of genotype 1 hepatitis C virus infection.
November 2011, BMJ (Clinical research ed.),
Fred Poordad
Hepatitis C virus infection: Are there still specific problems with genotype 3?
November 2015, World journal of gastroenterology,
Copied contents to your clipboard!